Original Research

DOI: 10.4244/EIJ-D-24-00116

A comparison of simplified or conventional antithrombotic regimens after left atrial appendage closure in patients at high bleeding risk: the PLATEBRISK study

Pablo Antúnez-Muiños1, MD, PhD; Sergio López-Tejero1, MD, PhD; Pedro Cepas-Guillén2, MD, PhD; Matias Mon-Noboa3, MD; Juan M. Ruiz-Nodar4,5, MD, PhD; Luis Andrés-Lalaguna6, MD, PhD; Fernando Rivero7, MD, PhD; Juan Gabriel Córdoba-Soriano8, MD, PhD; Ignacio J. Amat-Santos9, MD, PhD; Berenice Caneiro-Queija10, MD; David Martí Sánchez11, MD, PhD; Javier Jimeno Sánchez12, MD; Fernando Torres Mezcua4, MD; Fabián Blanco-Fernández1, MD; Jorge Sanz Sánchez7, MD, PhD; Cristina Moreno-Ambroj13, MD, PhD; Rodrigo Estévez-Loureiro10, MD, PhD; Luis Nombela-Franco3, MD, PhD; Xavier Freixa-Rofastes2, MD, PhD; Ignacio Cruz-González1, MD, PhD

Abstract

Background: Antithrombotic treatment (ATT) post-left atrial appendage occlusion (LAAO) remains controversial. Furthermore, most of the patients undergoing LAAO are at a very high bleeding risk.

Aims: This study aimed to compare a simplified versus conventional ATT after LAAO in very high bleeding risk patients.

Methods: This is a multicentre, retrospective study including very high bleeding risk patients, according to the Bleeding Academic Research Consortium (BARC) definition, who underwent LAAO. These included patients at >4% risk of BARC 3 to 5 bleeding or >1% risk of intracranial bleeding after the procedure. Two groups were established based on the discharge ATT. The simplified group included single antiplatelet treatment or no treatment, and the conventional group comprised dual antiplatelet treatment or anticoagulation (combined or not with antiplatelet therapy).

Results: A total of 1,135 patients were included. The mean CHA2DS2-VASc and HAS-BLED scores were 4.5±1.5 and 3.7±1.0, respectively. There were no differences in the composite endpoint (death, stroke, transient ischaemic attack, device-related thrombus or major bleeding) between the 2 groups (hazard ratio [HR] 0.81, 95% confidence interval [CI]: 0.59-1.11; p=0.188). Although the rate of major bleeding during the first year was numerically lower in the simplified group, it did not reach statistical significance (HR 0.67, 95% CI: 0.41-1.10; p=0.104). Nonetheless, patients with previous major bleeding presented a significantly lower rate of major bleeding when using the simplified treatment (HR 0.61, 95% CI: 0.36-0.99; p=0.049).

Conclusions: In patients with very high bleeding risk, a simplified ATT after LAAO seems to be as effective as conventional protocols. Furthermore, patients with a history of major bleeding experienced a lower risk of major bleeding with the simplified ATT.

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 20 Number 16
Aug 19, 2024
Volume 20 Number 16
View full issue


Key metrics

Suggested by Cory

10.4244/EIJ-D-17-00457R Oct 20, 2017
Left atrial appendage occlusion is promising, not concerning
free

Editorial

10.4244/EIJ-E-24-00041 Aug 19, 2024
Left atrial appendage occlusion needs lifetime management not lifetime medications
Gafoor S and Panaich S
free

CLINICAL RESEARCH

10.4244/EIJ-D-17-00901 Apr 6, 2018
Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices
Weise FK et al
free

FOCUS ARTICLE

10.4244/EIJY14M09_18 Jan 22, 2015
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion
Meier B et al
free
Trending articles
225.68

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
105.78

Expert consensus

10.4244/EIJ-E-22-00018 Dec 4, 2023
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M et al
free
77.85

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
68.7

Clinical research

10.4244/EIJ-D-21-00545 Sep 20, 2022
Coronary lithotripsy for the treatment of underexpanded stents: the international; multicentre CRUNCH registry
Tovar Forero M et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
45.3

Clinical research

10.4244/EIJ-D-18-01126 Aug 29, 2019
New-generation mechanical circulatory support during high-risk PCI: a cross-sectional analysis
Ameloot K et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved